0.8550806581371961		SimpleArgument(John,List([0, 4)))	Relation(focuses on,List([5, 12), [13, 15)))	SimpleArgument(medical diagnostic investments,List([16, 46)))	John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.
0.8550806581371961		SimpleArgument(John,List([0, 4)))	Relation(focuses on,List([5, 12), [13, 15)))	SimpleArgument(medical device,List([16, 30)))	John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.
0.5759228702523534		SimpleArgument(John,List([0, 4)))	Relation(joined Delphi Ventures in,List([5, 11), [12, 27), [49, 51)))	TemporalArgument(2003,List([52, 56)))	John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.
0.876543225140763		SimpleArgument(John,List([0, 4)))	Relation(joined Delphi Ventures as,List([5, 11), [12, 27), [28, 30)))	SimpleArgument(a General Partner,List([31, 48)))	John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.
0.876543225140763		SimpleArgument(John,List([0, 4)))	Relation(joined,List([5, 11)))	SimpleArgument(Delphi Ventures,List([12, 27)))	John joined Delphi Ventures as a General Partner in 2003 and focuses on medical device and diagnostic investments.
0.38089450366724514		SimpleArgument(John,List([26, 30)))	Relation(was Chairman of,List([31, 46)))	SimpleArgument(EndoTex Interventional Systems,List([47, 77)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.4953178616921359		SimpleArgument(Delphi,List([17, 23)))	Relation([is] John was Chairman of,List([26, 46)))	SimpleArgument(EndoTex Interventional Systems,List([47, 77)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8943349381932773	Context(start - up company focused,List([125, 151)))	SimpleArgument(John,List([26, 30)))	Relation(was Chairman of EndoTex Interventional Systems,List([31, 34), [35, 77)))	TemporalArgument(Prior to joining Delphi,List([0, 23)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8829339418736077	Context(start - up company focused,List([125, 151)))	SimpleArgument(John,List([26, 30)))	Relation(was,List([31, 34)))	SimpleArgument(Chairman of EndoTex Interventional Systems,List([35, 77)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.4953178616921359		SimpleArgument(Delphi,List([17, 23)))	Relation([is],List([17, 23)))	SimpleArgument(John was CEO,List([26, 38)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8943349381932773	Context(start - up company focused,List([80, 106)))	SimpleArgument(John,List([26, 30)))	Relation(was CEO,List([31, 34), [35, 38)))	TemporalArgument(Prior to joining Delphi,List([0, 23)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8829339418736077	Context(start - up company focused,List([80, 106)))	SimpleArgument(John,List([26, 30)))	Relation(was,List([31, 34)))	SimpleArgument(CEO,List([35, 38)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.4953178616921359		SimpleArgument(Delphi,List([17, 23)))	Relation([is],List([17, 23)))	SimpleArgument(John was President,List([26, 44)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8943349381932773	Context(start - up company focused,List([86, 112)))	SimpleArgument(John,List([26, 30)))	Relation(was President,List([31, 34), [35, 44)))	TemporalArgument(Prior to joining Delphi,List([0, 23)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.8829339418736077	Context(start - up company focused,List([86, 112)))	SimpleArgument(John,List([26, 30)))	Relation(was,List([31, 34)))	SimpleArgument(President,List([35, 44)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.9004708924659899		SimpleArgument(start - up company,List([86, 104)))	Relation(focused on,List([105, 112), [113, 115)))	SimpleArgument(commercialization of carotid artery stents,List([116, 158)))	Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.7130135287477929		SimpleArgument(venture,List([69, 76)))	Relation(backed,List([77, 83)))		Prior to joining Delphi, John was President, CEO and Chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents and which was acquired by Boston Scientific Corp. (NYSE:BSX) in 2007.
0.38089450366724514		SimpleArgument(EP Technologies,List([100, 115)))	Relation([is] Vice President of,List([118, 135)))	SimpleArgument(Operations,List([136, 146)))	From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS).
0.8019920579143587		SimpleArgument(John,List([20, 24)))	Relation(held a variety of senior management positions including General Manager at EP Technologies From,List([0, 4), [25, 102), [103, 115)))	TemporalArgument(1988 to 1997,List([5, 17)))	From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS).
0.9379113123569551		SimpleArgument(John,List([20, 24)))	Relation(held,List([25, 29)))	SimpleArgument(a variety of senior management positions including General Manager at EP Technologies,List([30, 115)))	From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS).
0.7532657647087118		SimpleArgument(John,List([20, 24)))	Relation(held a variety of senior management positions including President From,List([0, 4), [25, 80), [81, 90)))	TemporalArgument(1988 to 1997,List([5, 17)))	From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS).
0.9040259452709256		SimpleArgument(John,List([20, 24)))	Relation(held,List([25, 29)))	SimpleArgument(a variety of senior management positions including President,List([30, 90)))	From 1988 to 1997, John held a variety of senior management positions including President and General Manager at EP Technologies, Vice President of Operations at both Boston Scientific Corporation and Cardiovascular Imaging Systems (CVIS).
0.876543225140763		SimpleArgument(John,List([16, 20)))	Relation(was a key member of the senior management team during,List([21, 24), [25, 67), [68, 74)))	TemporalArgument(the eventual acquisition by Boston Scientific Corporation,List([75, 132)))	While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.
0.9124405450386827		SimpleArgument(John,List([16, 20)))	Relation(was a key member of the senior management team While,List([0, 5), [21, 62), [63, 67)))	TemporalArgument(at CVIS,List([6, 13)))	While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.
0.876543225140763		SimpleArgument(John,List([16, 20)))	Relation(was a key member of the senior management team during,List([21, 24), [25, 67), [68, 74)))	TemporalArgument(the Company 's IPO,List([75, 93)))	While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.
0.8867237254315935		SimpleArgument(John,List([16, 20)))	Relation(was,List([21, 24)))	SimpleArgument(a key member of the senior management team,List([25, 67)))	While at CVIS, John was a key member of the senior management team during the Company's IPO and eventual acquisition by Boston Scientific Corporation.
0.8571777395282005		SimpleArgument(John,List([0, 4)))	Relation(serves on the Advisory Board for,List([10, 16), [17, 38), [39, 42)))	SimpleArgument(the School of BioMedical Engineering at UC Davis,List([43, 91)))	John also serves on the Advisory Board for the School of BioMedical Engineering at UC Davis.
0.8571777395282005		SimpleArgument(John,List([0, 4)))	Relation(serves on,List([10, 16), [17, 19)))	SimpleArgument(the Advisory Board,List([20, 38)))	John also serves on the Advisory Board for the School of BioMedical Engineering at UC Davis.
